Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Paushak Limited, part of the Alembic Group, is India's largest manufacturer of phosgene-based specialty chemicals, with a strong focus on isocyanates and chloroformates among others.
The company operates out of a 'Responsible Care' certified plant in Gujarat with a capacity of 14,400 MT/year. It is notable for achieving high benchmarks in process safety and operational efficiencies.
Paushak engages in toll manufacturing and offers diverse chemical products used across pharmaceuticals, pesticides, dyes, and plastics, highlighting its versatile applications.
It maintains a substantial R&D footprint, supporting process development, with a dedicated in-house laboratory complementing its production capabilities.
Despite its niche focus in specialty chemicals, Paushak benefits from its association with Alembic Group, leveraging corporate support in various operational areas.
Chemicals & Petrochemicals
Specialty Chemicals
1,383 Cr
High Risk
41.4
44.1
1.2
2.8
991.20
343.00
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Jul 29, 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Paushak Ltd (PAUSHAKLTD) is currently trading at 565.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Paushak Limited, part of the Alembic Group, is India's largest manufacturer of phosgene-based specialty chemicals, with a strong focus on isocyanates and chloroformates among others. The company operates out of a 'Responsible Care' certified plant in Gujarat with a capacity of 14,400 MT/year. It is notable for achieving high benchmarks in process safety and operational efficiencies. Paushak engages in toll manufacturing and offers diverse chemical products used across pharmaceuticals, pesticides, dyes, and plastics, highlighting its versatile applications. It maintains a substantial R&D footprint, supporting process development, with a dedicated in-house laboratory complementing its production capabilities. Despite its niche focus in specialty chemicals, Paushak benefits from its association with Alembic Group, leveraging corporate support in various operational areas.
Over the past 52 weeks, Paushak Ltd has traded between a low of ₹343.00 and a high of ₹991.20. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Paushak Ltd has a market capitalization of approximately 1,383.01. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Paushak Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.43 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 1,383.01 Cr, Paushak Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Paushak Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Paushak Ltd is 41.43. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
2
Neutral
7
Bullish
5
Bearish
3
Neutral
7
Bullish
36
Bearish
1
Neutral
0
Bullish
31
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
306.25 | 1,543 Cr | 31.53 | 4.71 | 0.97 | 14.93 | 18.30 | 11.66 | ||
565.00 | 1,383 Cr | 41.43 | 2.82 | 0.45 | 8.01 | 9.02 | 5.96 | ||
369.10 | 1,251 Cr | 379.39 | 1.88 | 0.13 | 0.50 | 4.36 | 0.28 | ||
227.80 | 1,241 Cr | 23.71 | 2.80 | 0.00 | 11.73 | 15.16 | 9.33 | ||
941.65 | 1,184 Cr | 15.64 | 0.70 | 1.46 | 4.44 | 5.81 | 3.59 | ||
931.00 | 1,113 Cr | 15.90 | 4.09 | 0.97 | 24.23 | 31.96 | 16.45 | ||
1199.00 | 1,051 Cr | 35.51 | 4.17 | 0.25 | 11.74 | 17.68 | 9.70 | ||
| Median: 7 Co. | — | 565.00 | 1,241 Cr | 31.53 | 2.82 | 0.45 | 11.73 | 15.16 | 9.33 |
Board Meeting
Paushak Ltd will hold a Board meeting on 2026-07-30 to consider and approve unaudited financial results for the quarter ended 30 June 2026; trading window reopens 48 hours after declaration.
Board Meeting
Paushak Ltd will hold a Board meeting on 2026-07-30 to consider and approve unaudited financial results for the quarter ended 30 Jun 2026; trading window closed from 01 Jul 2026 will reopen 48 hours after results declaration.
